Jones, R. N., & Erwin, M. E. (1992). Preliminary disk diffusion susceptibility testing criteria for cefdaloxime (RU29246, HR-916 metabolite), a new orally administered cephalosporin.
Chicago Style aipamenaJones, R N., and M E. Erwin. Preliminary Disk Diffusion Susceptibility Testing Criteria for Cefdaloxime (RU29246, HR-916 Metabolite), a New Orally Administered Cephalosporin. 1992.
MLA aipamenaJones, R N., and M E. Erwin. Preliminary Disk Diffusion Susceptibility Testing Criteria for Cefdaloxime (RU29246, HR-916 Metabolite), a New Orally Administered Cephalosporin. 1992.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.